Laurent Fischer, CEO, Director at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 0.00 shares in CTI BioPharma (Ticker: CTIC), holds 7.69K shares in Adverum Biotechnologies (Ticker: ADVM). Most recently, Laurent Fischer ― shares of Tobira Therapeutics on ― for an estimated value of ―.
Laurent Fischer latest transaction was an Uninformative Buy of ―.
What was Laurent Fischer's most profitable transaction?
Laurent Fischer’s most profitable transaction was an Informative Buy of MIRM stock on September 18, 2019. The return on the trade was 112.00%.
What is Laurent Fischer's role in Tobira Therapeutics?
Laurent Fischer's role in Tobira Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.